D
David Spiegel
Researcher at Stanford University
Publications - 838
Citations - 50967
David Spiegel is an academic researcher from Stanford University. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 106, co-authored 733 publications receiving 46276 citations. Previous affiliations of David Spiegel include Tel Aviv University & University of Adelaide.
Papers
More filters
Journal ArticleDOI
Brain Activity and Functional Connectivity Associated with Hypnosis
TL;DR: Functional magnetic resonance imaging revealed changes in neural activity underlie the focused attention, enhanced somatic and emotional control, and lack of self-consciousness that characterizes hypnosis.
Journal ArticleDOI
Advancing psychosocial care in cancer patients.
TL;DR: This review examines some of the most significant related issues, also focusing on recent advances in psychosocial and psychopharmacological interventions as a part of a mandatory, integrated, and comprehensive approach to cancer care.
Journal ArticleDOI
Effects of supportive-expressive group therapy on pain in women with metastatic breast cancer.
Lisa D. Butler,Cheryl Koopman,Eric Neri,Janine Giese-Davis,Oxana Palesh,Krista A. Thorne-Yocam,Sue Dimiceli,Xin-Hua Chen,Patricia Fobair,Helena C. Kraemer,David Spiegel +10 more
TL;DR: Intention-to-treat analyses indicated that the intervention resulted in significantly less increase in the intensity of pain and suffering over time, compared to the education-only group, but had no significant effects on the frequency of pain episodes or amount of constant pain.
Journal ArticleDOI
Supportive-expressive group therapy for primary breast cancer patients: a randomized prospective multicenter trial.
Catherine C. Classen,Helena C. Kraemer,Christine Blasey,Janine Giese-Davis,Cheryl Koopman,Oxana Palesh,Ami Atkinson,Sue Dimiceli,Gail Stonisch-Riggs,Joan Westendorp,Gary R. Morrow,David Spiegel +11 more
TL;DR: Evaluated a manualized 12‐week supportive–expressive group therapy program among primary breast cancer patients treated in community settings to determine whether highly distressed patients were most likely to benefit and whether therapist's training or experience was related to outcome.